Committed to sharing our science

Committed to sharing our science

376 results available

Clinical Responses to Aficamten Monotherapy Compared with Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy Outcomes and Disease Burden: MAPLE-HCM Responder Analysis

Oral Presentation, AHA 2025

Wang, A et al.

November 8, 2025
Chronic Aficamten Treatment Results in Sustained Favorable Cardiac Remodeling in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the FOREST-HCM Trial

Poster, AHA 2025

Hegde, SM et al.

November 8, 2025
Aficamten is Safe and Effective in Obstructive Hypertrophic Cardiomyopathy With Comorbidities Obesity, Hypertension and Diabetes: A SEQUOIA-HCM Sub-study

Poster, AHA 2025

Lee, MMY et al.

November 8, 2025
Improvement in Echo Measures of Diastolic Function Reflects Improved Exercise Performance in Obstructive Hypertrophic Cardiomyopathy: Insights From the SEQUOIA-HCM Trial

Poster, AHA 2025

Lu, H et al.

November 8, 2025
Outcomes Following Septal Myectomy in Pediatric and Young Patients with Obstructive Hypertrophic Cardiomyopathy

Poster, HCMS 2025

Kamna, D et al.

November 7, 2025